DK0547545T3 - Farmaceutisk præparat til inhibering af knogleresorption - Google Patents

Farmaceutisk præparat til inhibering af knogleresorption

Info

Publication number
DK0547545T3
DK0547545T3 DK92121256.9T DK92121256T DK0547545T3 DK 0547545 T3 DK0547545 T3 DK 0547545T3 DK 92121256 T DK92121256 T DK 92121256T DK 0547545 T3 DK0547545 T3 DK 0547545T3
Authority
DK
Denmark
Prior art keywords
denotes
bone resorption
group
chem
pharmaceutical composition
Prior art date
Application number
DK92121256.9T
Other languages
Danish (da)
English (en)
Inventor
Hans-Jochen Dr Lang
Mizuho Inazu
Ryoichi Satoh
Tsutomu Inoue
Hiroshi Kitagawa
Masakazu Katoh
Heinrich Dr Englert
Denis Dr Carniato
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of DK0547545T3 publication Critical patent/DK0547545T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92121256.9T 1991-12-16 1992-12-14 Farmaceutisk præparat til inhibering af knogleresorption DK0547545T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33176791 1991-12-16
JP23914492A JP3502403B2 (ja) 1991-12-16 1992-09-08 骨吸収抑制剤

Publications (1)

Publication Number Publication Date
DK0547545T3 true DK0547545T3 (da) 1995-05-15

Family

ID=26534099

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92121256.9T DK0547545T3 (da) 1991-12-16 1992-12-14 Farmaceutisk præparat til inhibering af knogleresorption

Country Status (10)

Country Link
US (1) US5317029A (de)
EP (1) EP0547545B1 (de)
JP (1) JP3502403B2 (de)
KR (1) KR100257496B1 (de)
AT (1) ATE114465T1 (de)
CA (1) CA2085421A1 (de)
DE (1) DE69200757T2 (de)
DK (1) DK0547545T3 (de)
ES (1) ES2066546T3 (de)
TW (1) TW223016B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
US5389646A (en) * 1993-12-30 1995-02-14 Zymogenetics, Inc. Methods for treatment and prevention of bone loss using 2,3-benzopyrans
GB9408577D0 (en) * 1994-04-29 1994-06-22 Fujisawa Pharmaceutical Co New compound
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
EP0783888A1 (de) * 1995-12-26 1997-07-16 Sankyo Company Limited Verwendung von Troglitazone und verwandten Thiazolidinedionen zur Herstellung eines Medikaments für die Behandlung und Vorbeugung der Osteoporose
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
KR100389127B1 (ko) * 2000-10-09 2003-06-25 동부한농화학 주식회사 벤조피라닐 헤테로고리 유도체, 그의 제조방법 및 그를포함하는 약학적 조성물
TWI396543B (zh) * 2005-05-12 2013-05-21 Sankyo Co 取代丙烯醯胺衍生物及含有它之醫藥組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) * 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
DE3364145D1 (de) * 1982-04-08 1986-07-24 Beecham Group Plc Antihypertensive benzopyranols
JPS58219183A (ja) * 1982-04-28 1983-12-20 ビ−チヤム・グル−プ・ピ−エルシ− 新規なクロマノ−ル,その製法及びそれらを含む製薬組成物
DE3368629D1 (en) * 1982-04-28 1987-02-05 Beecham Group Plc Novel chromenes and chromans
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3823533A1 (de) * 1988-07-12 1990-02-08 Beiersdorf Ag Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate

Also Published As

Publication number Publication date
JPH05221860A (ja) 1993-08-31
EP0547545B1 (de) 1994-11-30
US5317029A (en) 1994-05-31
JP3502403B2 (ja) 2004-03-02
DE69200757T2 (de) 1995-05-11
EP0547545A1 (de) 1993-06-23
KR100257496B1 (ko) 2000-08-01
ATE114465T1 (de) 1994-12-15
KR930012036A (ko) 1993-07-20
ES2066546T3 (es) 1995-03-01
DE69200757D1 (de) 1995-01-12
TW223016B (de) 1994-05-01
CA2085421A1 (en) 1993-06-17

Similar Documents

Publication Publication Date Title
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
DK0547545T3 (da) Farmaceutisk præparat til inhibering af knogleresorption
CA2335285A1 (en) Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
EP1775289A4 (de) Neue imidazolidinderivate
NZ329656A (en) Oxazole and thiazoles derivatives containing a fibrinogen receptor antagonist template
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
UA66864C2 (uk) Похідні сечовини, фармацевтична композиція і спосіб лікування або профілактики запальних, аутоімунних або респіраторних захворювань
DE68924681D1 (de) Heterocyclische Biphosphonsäurederivate.
TWI265929B (en) Triazinyl derivatives for inhibiting the production of IL-12
ATE247089T1 (de) Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
EP0903347A4 (de)
WO2000064874A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DK0659427T3 (da) 2-Phenyl-3-azoylbenzothiophener til forøgelse af thrombomodulinekspression
DK0488513T3 (da) Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen
HK1068332A1 (en) Pyrane derivatives as both ace-and nep-inhibitors
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
DE69823240D1 (de) Immunmodulierende arzneimittelzusammenstellung
EP0385446A3 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten
DE69320911D1 (de) Chinuclidine derivate als squalen synthase inhibitore
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.
BR0014447A (pt) Derivados de piperidina como inibidores da reabsorção
BR0014668A (pt) Derivados de piperidina como inibidores de reabsorção de serotonina